Litigation Details for XMTT, Inc. v. Intel Corporation (D. Del. 2018)
✉ Email this page to a colleague
XMTT, Inc. v. Intel Corporation (D. Del. 2018)
| Docket | ⤷ Try a Trial | Date Filed | 2018-11-16 |
| Court | District Court, D. Delaware | Date Terminated | |
| Cause | 35:271 Patent Infringement | Assigned To | Richard Gibson Andrews |
| Jury Demand | Plaintiff | Referred To | |
| Patents | 10,022,344; 10,034,841; 10,034,879; 10,034,904; 10,071,977; 10,080,841; 10,344,029; 10,344,037; 10,370,438; 7,037,707; 7,879,027; 7,879,842; 7,977,080; 8,003,853; 8,017,582; 8,026,344; 8,034,904; 8,114,582; 8,133,707; 8,133,977; 8,158,853; 8,344,007; 8,415,133; 8,669,051; 9,033,344; 9,040,505; 9,051,582; 9,084,853; 9,505,841; 9,669,068; 9,707,302; 9,879,026; 9,967,068; 9,977,036; 9,977,039 | ||
| Link to Docket | External link to docket | ||
Small Molecule Drugs cited in XMTT, Inc. v. Intel Corporation
The small molecule drugs covered by the patents cited in this case are ⤷ Try a Trial , ⤷ Try a Trial , ⤷ Try a Trial , ⤷ Try a Trial , ⤷ Try a Trial , and ⤷ Try a Trial .
Biologic Drugs cited in XMTT, Inc. v. Intel Corporation
The biologic drugs covered by the patents cited in this case are ⤷ Try a Trial , ⤷ Try a Trial , ⤷ Try a Trial , ⤷ Try a Trial , ⤷ Try a Trial , ⤷ Try a Trial , ⤷ Try a Trial , ⤷ Try a Trial , ⤷ Try a Trial , ⤷ Try a Trial , ⤷ Try a Trial , ⤷ Try a Trial , ⤷ Try a Trial , ⤷ Try a Trial , ⤷ Try a Trial , ⤷ Try a Trial , ⤷ Try a Trial , ⤷ Try a Trial , ⤷ Try a Trial , ⤷ Try a Trial , ⤷ Try a Trial , ⤷ Try a Trial , ⤷ Try a Trial , ⤷ Try a Trial , ⤷ Try a Trial , ⤷ Try a Trial , ⤷ Try a Trial , ⤷ Try a Trial , ⤷ Try a Trial , ⤷ Try a Trial , ⤷ Try a Trial , and ⤷ Try a Trial .
Details for XMTT, Inc. v. Intel Corporation (D. Del. 2018)
| Date Filed | Document No. | Description | Snippet | Link To Document |
|---|---|---|---|---|
| 2020-05-12 | 117 | Opinion - Memorandum Opinion | modules.” (’388 patent, 7:1-7; ’879 patent, 7:10-16). “[A]s a general rule claims of a patent are not limited…-19, 15:3-4, 20-23; ’879 patent, col. 2:48-50, 3:25-26, 9:32-33, 52-53, 11:22-23). For example, claim…terms in U.S. Patent Nos. 7,707,388 (“the ’388 patent”) and 8,145,879 (“the ’879 patent”). The Court … Wellcome, Inc. v. Andrx Pharmaceuticals, Inc., 344 F.3d 1226, 1233 (Fed. Cir. 2003). I therefore…infringement of the ’388 and ’879 patents. (D.I. 1). The asserted patents are directed to a “computer memory | External link to document |
| >Date Filed | >Document No. | >Description | >Snippet | >Link To Document |
